{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/69911-475#drug","name":"AFSTYLA Antihemophilic Factor (Recombinant), Single Chain","alternateName":"ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"69911-475"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"BLA125591"}],"activeIngredient":"","administrationRoute":[],"dosageForm":"KIT","manufacturer":{"@type":"Organization","name":"CSL Behring Lengnau AG"},"drugClass":[],"isAvailableGenerically":false,"legalStatus":"PLASMA DERIVATIVE","sameAs":["https://api.morvs.ai/drug-approval/BLA125591","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69911-475"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-01T03:33:06.049Z"}}